Journal article icon

Journal article

Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Abstract:

Long-term beta blockade for perhaps a year or so following discharge after an MI is now of proven value, and for many such patients mortality reductions of about 25% can be achieved. No important differences are clearly apparent among the benefits of different beta blockers, although some are more convenient than others (or have slightly fewer side effects), and it appears that those with appreciable intrinsic sympathomimetic activity may confer less benefit. If monitored, the side effects of...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
Journal:
Progress in cardiovascular diseases
Volume:
27
Issue:
5
Pages:
335-371
Publication date:
1985-01-01
DOI:
EISSN:
1873-1740
ISSN:
0033-0620
Source identifiers:
42376
Language:
English
Keywords:
Pubs id:
pubs:42376
UUID:
uuid:17bf6650-cdb7-4515-80fb-ba4bd9a355ff
Local pid:
pubs:42376
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP